SCHEMBL807652

SCHEMBL807652

COc1cccc(F)c1CN1[C@@H]2CCC[C@H]1CC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.47
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ABCB1 P08183 2/20 0.46
OPRM1 P35372 2/20 0.44
OPRD1 P41143 2/20 0.44
DRD3 P35462 1/20 0.43
KDM1A O60341 1/20 0.43
MAOA P21397 1/20 0.43
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
KCNH2 Q12809 1/20 0.41
SCN8A Q9UQD0 1/20 0.39
JAK2 O60674 1/20 0.39
JAK3 P52333 1/20 0.39
GNRHR P30968 2/20 0.39
CXCR6 O00574 1/20 0.39
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL807487 0.86 OPRM1 (0.55) ABCB1OPRM1OPRD1SCN8A
SCHEMBL806942 0.86 OPRM1 (0.55) ABCB1OPRM1OPRD1SCN8A
SCHEMBL15084313 0.83 MAPK1 (0.42) SIGMAR1MAPK1SMN1; SMN2ABCB1OPRM1
SCHEMBL15081993 0.80 MAPK1 (0.40) SIGMAR1MAPK1SMN1; SMN2ABCB1OPRM1
SCHEMBL807451 0.79 MAPK1 (0.39) SIGMAR1MAPK1SMN1; SMN2ABCB1OPRM1
SCHEMBL30662723 0.78 SIGMAR1 (0.49) SIGMAR1MAPK1SMN1; SMN2OPRM1OPRD1
SCHEMBL22331204 0.78 SIGMAR1 (0.49) SIGMAR1MAPK1SMN1; SMN2OPRM1OPRD1
SCHEMBL22331167 0.78 SIGMAR1 (0.51) SIGMAR1MAPK1SMN1; SMN2ABCB1OPRM1
SCHEMBL10212378 0.77 MAPK1 (0.63) MAPK1SMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL807356 0.76 MAPK1 (0.62) MAPK1SMN1; SMN2SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012036997-A1 FUSED PYRAZOLE DERIVATIVES AS NOVEL ERK INHIBITORS SCHERING CORPORATION (US) 2012-03-22 WO disclosed